Stockholm 20 January 2023 As one of the first Swedish SME companies, Zenicor has been certified according to the new EU Medical Device Regulation (MDR). […]
Stockholm 30 March 2023 Zenicor has today been awarded SEK 2.7 million by Sweden’s innovation agency Vinnova through the Swelife and Medtech4Health program “Collaborative project […]
Feasibility of screening for atrial fibrillation in a domiciliary setting: opportunistic one-time screening at preventive home visits in municipalities Poulsen P-B. , Hemmingsen U., Melgaard […]
During the European Digital Heart Congress ESC, the health economic results from the STROKESTOP study were presented for the first time. The study where the […]
Zenicor-ECG successfully used in another mass screening study for atrial fibrillation including 28 000 individuals. The goal of the study is to reduce stroke incidences […]
Zenicor has signed an agreement with a primary care provider in the English National Health Service (NHS) regarding the introduction of a more efficient care […]
Daiichi-Sankyo UK Ltd and Zenicor Medical Systems AB has entered an agreement where Daiichi-Sankyo part-funds a pilot project in which we introduce a new care […]
Article from the Department of Public Health and Primary Care/Primary Care Unit at the University of Cambridge https://www.phpc.cam.ac.uk/pcu/could-screening-for-a-common-heart-condition-called-atrial-fibrillation-help-prevent-strokes/
